SINGAPORE: Singapore-headquartered biotech firm Hummingbird Bioscience, known for developing antibodies for cancer, is ...

It will be adapting antibody-drug conjugates which it developed for cancer treatment to target these diseases.  Read more at ...

In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that ...

FibroSIGHT™ Plus marks another advancement in HistoIndex’s efforts to integrate its digital pathology solutions into routine ...

Studying dogs and cancer is a way to learn about cancer in people. It’s not that dogs and owners share exposures to ...

The uncertainty surrounds who will be able to get updated vaccines in coming months – shots created to protect against more ...

Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...

The countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast .

Early combination therapy could translate into fewer downstream hospitalizations and lower costs associated with dialysis and cardiovascular complications.

A professor has said how he is 'impressed' with tests carried out on lab mice that could prove groundbreaking in the race for a cure.